These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9494680)

  • 1. Infections due to group A streptococcus: new concepts and potential treatment strategies.
    Norrby SR; Norrby-Teglund A
    Ann Acad Med Singap; 1997 Sep; 26(5):691-3. PubMed ID: 9494680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic shock-like syndrome caused by streptococci].
    van Dissel JT; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1452-5. PubMed ID: 10443259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.
    Carapetis JR; Jacoby P; Carville K; Ang SJ; Curtis N; Andrews R
    Clin Infect Dis; 2014 Aug; 59(3):358-65. PubMed ID: 24785239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-hemolytic streptococcal bacteremia in adults].
    Rantala S
    Duodecim; 2013; 129(14):1477-84. PubMed ID: 23961606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
    Stevens DL
    Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
    Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
    Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial commentary: step on the GAS: are we almost there for clindamycin and intravenous immunoglobulin?
    Tan LK; Sriskandan S
    Clin Infect Dis; 2014 Aug; 59(3):366-8. PubMed ID: 24785238
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature.
    Tilanus AM; de Geus HR; Rijnders BJ; Dwarkasing RS; van der Hoven B; Bakker J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e208-12. PubMed ID: 19914115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
    Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
    Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
    Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
    J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic shock syndrome: major advances in pathogenesis, but not treatment.
    Low DE
    Crit Care Clin; 2013 Jul; 29(3):651-75. PubMed ID: 23830657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.
    Parks T; Wilson C; Curtis N; Norrby-Teglund A; Sriskandan S
    Clin Infect Dis; 2018 Oct; 67(9):1434-1436. PubMed ID: 29788397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive group A streptococcal disease.
    Stevens DL
    Infect Agents Dis; 1996 Jun; 5(3):157-66. PubMed ID: 8805078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
    Baxter M; Morgan M
    Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model.
    Tarnutzer A; Andreoni F; Keller N; Zürcher C; Norrby-Teglund A; Schüpbach RA; Zinkernagel AS
    Clin Microbiol Infect; 2019 Apr; 25(4):512.e7-512.e13. PubMed ID: 30025835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periorbital necrotizing fasciitis in a previously healthy male.
    Brissette A; Davidson J; Le Saux N; McGraw R; Kratky V; Jinapriya D
    Can J Ophthalmol; 2014 Dec; 49(6):e138-9. PubMed ID: 25433747
    [No Abstract]   [Full Text] [Related]  

  • 17. Rare presentation of necrotising fasciitis and streptococcal toxic shock syndrome by group A streptococcus.
    Saeed S; Alothman S; Ahmed L; Donaldson B
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28954758
    [No Abstract]   [Full Text] [Related]  

  • 18. Necrotizing fasciitis.
    Cherneski CL; Embil JM
    Saudi Med J; 2001 Jul; 22(7):565-8. PubMed ID: 11479634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic shock-like syndrome caused by streptococci--treated with clindamycin].
    Nørgaard M
    Ugeskr Laeger; 1997 Apr; 159(16):2396-7. PubMed ID: 9163118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review.
    Cawley MJ; Briggs M; Haith LR; Reilly KJ; Guilday RE; Braxton GR; Patton ML
    Pharmacotherapy; 1999 Sep; 19(9):1094-8. PubMed ID: 10610017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.